Enteral LactoFerrin In Neonates

Phase 3

Completed

• Conditions: Preterm infants, necrotising enterocolitis, late-onset invasive infection, lactoferrin; Digestive System; Necrotising enterocolitis

• Registration Number: ISRCTN88261002
• Lead Sponsor: niversity of Oxford (UK)

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30574860 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30635141

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-06-13
• Study Completion: 2018-05-31
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2200

Inclusion Criteria

Infants will be eligible to participate if:
1. Gestational age at birth is less than 32 weeks
2. Less than 72 hours old
3. Written informed parental consent is obtained

If infants are receiving antibiotic treatment for suspected or confirmed
Infection, they are still eligible for recruitment.

Exclusion Criteria

1. Infants with severe congenital anomalies
2. Anticipated enteral fasting of more than 14 days
3. Infants who, in the opinion of the treating clinician, have no realistic prospect of survival

Study & Design

• Study Type: Interventional
• Study Design: Not specified